NURS FPX 4025 Assessment 1: Analysis of Article
Brennan and colleagues (2024) used a qualitative systematic review in NURS FPX 4025 assessment 1 to make recommendations for the use of beta-blockers in patients with acute decompensated heart failure. This paper is a systematic review since it looks at academic literature that is supported by evidence within a given time frame and then analyzes the results to draw a conclusion. The review has category 1.b since it includes randomized control trials and other kinds of research. There are several factors that contribute to the article’s credibility. In analyzing a research paper published in the peer-reviewed academic journal Ochsner Journal; in order to support their discussion and ideas, the authors of the developed article also cited thirty scholarly articles. Since this article was only released in September 2024, it is still relevant even if it isn’t even a year old.
In their research paper, Brennan and colleagues (2024) discuss the use of beta-blockers in patients who were admitted with acute decompensated heart disease and had heart failure (reduced ejection fraction). The researchers also acknowledge that while beta-blocker use is generally high among heart failure patients, it is low among those admitted to hospitals with acute decompensated heart failure (Brennan et al., 2024). The paper by Brennan and co-authors examined a systematic analysis of studies conducted between 2004 and 2024 for this NURS FPX 4025 assessment 1. The authors came to the conclusion that patients with acute decompensated heart failure benefited from both starting and continuing beta-blocker medication (Brennan et al., 2024). An evidence-based guideline flowchart is suggested in this example of a research paper to assist clinicians in determining when to start and stop beta-blockers
The information is especially applicable to the diagnosis of heart failure. In the particular context of inpatient care, it examines directly the pharmaceutical recommendations that impact the prognoses of patients with chaotic hearts. The importance of beta-blocker therapy for heart failure patients, the maintenance of therapeutic doses of beta-blocker medications during hospital stays, and the improvement of adhering patient outcomes when beta-blocker medication is administered to patients admitted with acute decompensatory heart failure are all highlighted by analyzing a research paper. As mentioned in NURS FPX 4025 assessment 1, the information provided in this article can help nurses who are caring for patients in this group comprehend the value of medication adherence and the necessity of continuing to take beta-blockers.
Article Link
References
Brennan, M. T., Harmouch, K. M., Basit, J., & Chadi Alraies, M. (2024). Beta-Blocker usage in patients with heart failure with reduced ejection fraction during acute decompensated heart failure hospitalizations. The Ochsner Journal, 24(3), 198-203. https://doi.org/10.31486/toj.24.0011
